Breadcrumb

MolMed Symposium

Inaugural

MolMed Symposium - "Translational Medicine Activities at UC Riverside"

Tuesday, March 26, 2019

Genomics Auditorium and Lobby


Sir Thomas Blundell

Keynote Speaker: Sir Thomas Blundell, F.R.S., F.Med.Sci.

Department of Biochemistry at Cambridge University

"Structural Biology, Bioinformatics and Drug Discovery for Cancer and Tuberculosis: Fighting the Emergence of Resistance"

2019 Symposium Schedule

8:30 a.m.

Registration & Continental Breakfast

9:00 a.m.

Symposium Opens

Welcome and Introduction to the Center for Molecular and Translational Medicine at UCR
Deborah Deas, M.D., M.P.H., The Mark & Pam Rubin Dean, School of Medicine - University of California, Riverside
Chief Executive Officer for Clinical Affairs
and the MolMed Organizing Committee

9:15 a.m. — 11:15 p.m.

Novel Screening Approaches for Small Molecules and Antibodies

Chair: Michael Pirrung, Ph.D.

Sika Zheng, Ph.D

School of Medicine, University of California, Riverside
"A novel robust screening strategy for NMD-modulatory molecules"

Jiayu Liao, Ph.D.

Bourns College of Engineering, University of California, Riverside
"Novel strategy of developing therapeutics for anti-influenza virus and drug resistant strains by targeting host factors"

Xin Ge, Ph.D.

Bourns College of Engineering, University of California, Riverside
"A Monoclonal Antibody Treatment for Neuropathic Pain"

Robert Damoiseaux, Ph.D.

University of California, Los Angeles
"Building a Drug Discovery and Development Pipeline at UCLA"

11:15 a.m. — 11:30 a.m.

Coffee Break

11:30 a.m. - 1:00 p.m.Genomics

Genomics and Structure-Based Drug Design

Chair: Jiayu Liao, Ph.D.

Rong Hai, Ph.D.

College of Natural and Agricultural Sciences, University of California, Riverside
"Identification of Small Molecule Inhibitors of Zika Virus Infection"

Jeff Perry, Ph.D.

College of Natural and Agricultural Sciences, University of California, Riverside
"Targeting neuroblastoma and age-related macular degeneration through structure-based drug design efforts"

Adam Godzik, Ph.D.

School of Medicine, University of California, Riverside
"Genomics in Drug Design"

1:00 - 2:00 p.m.

Lunch buffet and Posters viewing

2:15 - 3:30 p.m.

UCR and UC-wide Translational Medicine Initiatives and Opportunities

Chair: Maurizio Pellecchia, Ph.D.

Mark Leibowitz, Ph.D.

Office of Technology Partnerships, University of California, Riverside
"The MRB1 Incubator space and other initiatives supporting UCR spin off companies in translational medicine"

Joseph Wagner, Ph.D.

University of California, Davis
"The UC-Wide Drug Discovery Consortium"

Michael Gilson, Ph.D.

University of California, San Diego
"The UC San Diego Center for Drug Discovery Innovation (CDDI)"

Vinita Roy, MBA

COVANCE
"EPDS and Marketplace by Covance"

3:30 - 4:15 p.m.

Coffee Break and Poster Session - Optional Walk to Tour the UCR Incubator Space

4:20 - 5:00 p.m.

Towards Novel UCR Therapeutics

Chair: Jeff Perry, Ph.D.

Maurizio Pellecchia, Ph.D.

School of Medicine, University of California, Riverside
"Targeting tumor metastases via the EphA2 receptor: changing the face of chemotherapy"

Michael Pirrung, Ph.D.

College of Natural and Agricultural Sciences, University of California, Riverside
"Anticancer Proteasome Inhibitors"

Learn more about Michael Pirrung's research

5:00 - 6:00 p.m.

Keynote Lecture
Sir Thomas Blundell, F.R.S., F.Med.Sci.

Department of Biochemistry at Cambridge University, UK
"Structural Biology, Bioinformatics and Drug Discovery for Cancer and Tuberculosis: Fighting the Emergence of Resistance"

6:00 - 7:00 p.m.

Award Presentations & Reception

Light refreshments will be served

Search